INTRODUCTION
Recently the presence of "cold lymphocytotoxin" was shown in patients with infections such as rubella, rubeola, This paper was presented in part at the annual meeting of the Society for Pediatric Research, Atlantic City, N. J. 29 April 1971. Dr. Huang is an Allergy Foundation Fellow. Received for publication 20 July 1972 and in revised form 15 November 1972. and infectious mononucleosis (2) . Many previously described cytotoxins related to diseases were shown to be most active at cold temperatures when tested in vitro (2) . It is unknown whether such lymphocytotoxins could have any direct effect at normal body temperature.
In addition, some cytotoxins effective at 37'C have been observed (3) (4) (5) (6) .
We recently observed four cases in our hospitals that suddenly developed lymphopenia (defined as < 1,500/ mm') and severe clinical illness in the wake of a viral or mycoplasma infection. In a fifth, a vague febrile illness preceded by 10 days a terminal varicella infection. These observations prompted us to investigate the incidence and mechanism of lymphopenia associated with some infectious agents.
METHODS
Source of sera. In addition to the five original cases, sera were obtained from 48 cases of various viral and 22 of mycoplasma infections. Diagnosis was verified by isolation of the agents and demonstration of at least a fourfold rise in antibodies in convalescent sera. Acute sera were collected within 7 days after the onset of illness and convalescent sera were collected between 15-25 days after the onset of illness. Four age-matched control sera were obtained for each test sample. Two were obtained from cases with febrile illnesses without elevation of any viral antibodies in subsequent sera and two were from cases with various viral illnesses and subsequent elevation of antibody titers but which did not develop lymphopenia. None of these control cases were shown to have bacterial infection. The white blood cells were taken at the time when acute and convalescent sera were obtained except in two cases. Sera were also obtained from 11 individuals 2 wk after immunization with live measles virus. 22 healthy adults were also selected as normal controls.
Detection of lymphocytotoxicity. Cytotoxicity was tested by Terasaki' s microdroplet method (1) . Test (8) . Immunoglobulins were absorbed from test sera by exposure to the immunoabsorbent for 60 h at 40C using constant agitation. Quantitation of the serum immunoglobulins by single radial diffusion (9) revealed that 96% of IgG, 90% of IgA, and 99% of IgM were removed. Simultaneous quantitation of albumin showed no change indicating the specificity of the immunoabsorption.
Specificity of the lymphocytotoxic effect. In order to test the specificity of the lymphocytotoxic effect, several human cell lines were utilized as target cells for 10 positive sera. Inadequate amounts precluded testing of all positive samples. The cell lines employed were HeLa, Hep-2, Wis-L (p-7, fetal epithelial cells), Wis-L (p-24, fetal fibroblasts), and WI-38 (p-25, lung fibroblasts). Cell concentrations were adjusted to 1 X 10 cells/milliliter for cytotoxicity tests. Viruses, serum samples, and complement were added in order as described above in the detection of lymphocytotoxicity. Subsequently, those cells were subcultured to detect any possible deleterious effect on the formation of monolayers.
Human granulocytes from peripheral blood were isolated by B6yum's method (10) from three of the donors and were also tested for cytotoxicity. Human peripheral lymphocytes from the same donors after incubation with sheep red blood cells were separated by Ficoll Hypaque (Pharmacia Fine Chemicals, Inc.) density gradient into subpopulations of rosette-forming cells (RFC) and nonrosette-forming cells (n-RFC) 1 and each group was used as target cells for the above 10 positive sera.
Appropriate controls were prepared for each experiment as described above and all the tests were performed at 37°C. 48 cases with viral infections showed that 15 cases had lymphopenia while 4 of 22 cases with mycoplasma infection developed lymphopenia (Table I) . No single agent seems more prone to induce lymphopenia. All of those cases which developed lymphopenia showed lymphocytotoxic activity against normal lymphocytes in their acute phase sera (Table II) . Five cases (Appendix) from whom lymphocytes were obtained and tested against their own sera showed autocytotoxicity. Two cases which had peripheral blood lymphocyte counts of more than 1,500/mm3 showed only weak cytotoxic activity in their sera'.
RESULTS

Screening among
'Abbreviations used in this paper: AbAL, antibody-associated lymphotoxin; CMI, cell-mediated immunity; n-RFC, nonrosette-forming cells; RFC, rosette-forming cells. Preceding infection assumed; no definite agent recovered. ** Cases without lymphopenia but which showed cytotoxicity.
Of 11 cases immunized with live measles virus, only one showed cytotoxic activity at 371C. However, four other cases showed cytotoxic activity at 4VC incubation in sera obtained 2 wk after immunization. Lymphopenia was not present. With the exception just mentioned, all the cytotoxic agents of the positive sera showed certain common characteristics: (a) optimal activity at 370C, (b) complement dependency, and (c) ease of demonstration in acute phase sera but essentially nondetectable in convalescent sera (0 in 12, 1 + in 3) .
Reactivation of the cytotoxic activity of the acute sera was observed after addition of viruses to test cells by either of the methods described above. These results are shown on Table Ill . It can be seen that increased cytotoxicity was obtained after addition of appropriate viruses in nearly all cases and frequently the return was equal to or greater than the original activity. Cytotoxicity could not be produced in any of the convalescent sera by the addition of virus.
In an attempt to further define the nature of the serum factor(s), immunoglobulins were removed by incubation with an antilight chain immunoabsorbent. Absorbed sera did not show lymphocytotoxic activity, and the addition of viruses had no effect on reconstitution of the absorbed sera.
11 of the positive sera were separated into 7S and 19S fractions and the fractions were tested for cytotoxicity as described above. In all serums, the cytotoxicity seemed to reside in the 19S fraction and in only three sera was there activity in the 7S fraction. None of the human tissue culture cell lines in suspension demonstrated cellular damage as shown by eosin dye exclusion tests during microcytotoxicity tests and further, there were no deleterious effects which prevented formation of monolayers. Treated cell lines were identical to controls over a period of a 72 h observation. In addition, no cytotoxic effect was demonstrable against granulocytes obtained from three normal donors.
When the cytotoxicity test was done on RFC's (T cells) and n-RFC's (B cells) (11) (12) (13) (2) (3) (4) (5) (6) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . Some of the previously described lymphocytotoxins showed cytolytic activity best at cold temperatures (150C) and complement dependency. Some were associated with various autoantibodies (16) or with certain types of HL-A antigens (22) . Others have been described in association with certain phases of different clinical diseases (2-6, 19) . The clinical significance of the "cold toxins" at body temperatures, however, is not yet well understood, although it has been speculated that they might be biologically active in a way similar to cryoglobulins or cold autohemolysin anti-i (28). For reasons of clarity, we refer to our serum factor as antibody-associated lymphotoxin (AbAL). This avoids confusion with lymphocytotoxins which are lymphokines produced as part of a cell-mediated immune reaction (29) .
Screening of cases whose specimens were referred for virological studies showed that 15 out of 48 had lymphopenia (absolute count of lymphocytes less than 1,500/mm3) during certain periods of acute infections. The lymphopenia in all cases was correlated with the presence of AbAL and the return to normal (usually within 2-3 wk) was associated with loss of lymphocytotoxic activity of the sera. As indicated in Table II, there were only two patients who did not have lymphopenia by the above criteria, yet their sera had cytotoxic activity. This might be due to the fact that their counts were not taken until several days after the acute sera had been drawn. Most of the convalescent sera showed only weak or no cytotoxic activity.
The fact that diminution of the activity of the sera was observed after absorption with antilight chain antibody suggested that the cytotoxic factor was immunoglobulin in nature. Further studies demonstrated that the cytolytic action could be produced by adding virus, serum containing its specific antibody and complement to the testing lymphocytes. The We also demonstrated that the cytotoxic activity mainly resides in the 19S fraction of the sera; three sera also showed some activity in the 7S fraction. The convalescent sera failed to demonstrate significant cytotoxic activity. Additionally, the possibility of a "blocking factor" in the convalescent sera has not been ruled out. It is possible that IgM was the major antiviral antibody in the acute phase while in the convalescent phase IgG was predominant.
At the time when the cytotoxic agent was demonstrable in the serum sample, titers of complement-fixing antivirus antibody were 1: 8 or less. Also, during convalescence, when complement-fixing titers had risen fourfold or more, virus-serum cytotoxicity effects had disappeared. Thus, the agent seems different from classic antibody as detected by usual complement-fixing methods. However, the sedimentation characteristics and the association with light chain determinants lead us to believe that the agent is an antibody.
Human cell lines other than lymphocytes were also tested in the same cytotoxicity system but there was no cytotoxic effect seen among those cell lines nor with granulocytes. In preliminary tests, the cytotoxic activity seemed to be greater for T lymphocytes than B lymphocytes. Further effects upon cell-mediated immunity (CMI) function are still under study but if these results are substantiated they may bear upon the transient anergy noted in various viral infections (30) .
There is a form of immunological deficiency in humans reported by Kretschmer, Janeway, and Rosen (26) in which a patient was noted to have dysgammaglobulinemia and also lymphopenia due to the presence of lymphocytotoxic antibody. As expected, she manifested failure of lymphocyte-dependent functions including allograft rejection, delayed hypersensitivity, and immunologic memory. It is interesting to note that her serum lymphotoxic antibody was associated with y-A globulin and that bouts of recurrent profound lympho- Table  II) ; both patients had been known to be healthy previously. Case 14 succumbed to disseminated varicella. He had had live virus immunizations previously without any complication. Postmortem studies showed the depletion of small lymphocytes from the lymph nodes. Unfortunately, the thymus was not studied and the cause of the previous infection was not clear. Case 7 apparently was exposed to measles resulting in elevation of measles antibody, although she did not demonstrate clinical disease. While she was having lymphopenia she was infected with Candida albicans and a Staphylococcus aureus of an unusual phage type. She developed the scalded skin syndrome which is extremely rare in this age group. The restriction of the scalded skin syndrome to the very young in human and experimental situations suggests some immunologic compromise as important in its etiology. In the two cases just mentioned, it is postulated that AbAL induced sufficient impairment of immunity to allow the unusual expression of a superimposed infectious agent. Recently, Dudding and his associates (31 ) reported three fatal cases of pneumonia associated with adenovirus type 7. The patients were previously in good health but succumbed to death after a brief fulminant illness. One striking feature of those cases was persistent lymphopenia. Although the superimposition of other bacterial infection or other viral infections was not clear in their cases, the clinical picture was very similar to acute acquired immunologic deficiency which occurred in our two cases.
Three other patients had less severe illnesses as compared to the above cases and recovered. All their lymphocyte counts returned to normal with the disappearance of AbAL except one patient, Case She was discharged 2 wk later after a complete recovery. She had been exposed to measles before the acute illness and acquired an elevated antibody titer without clinical disease.
Case 8, a 12-yr-old male, had a history of a febrile illness for a week followed by a generalized skin rash. He also had conjunctivitis, stomatitis, and left lower lobe pneumonia. His absolute lymphocyte count was 500/mm3 on admission and 2,576/mm3 on the 10th hospital day. He had an initial elevation of Herpes simplex antibody titer and mycoplasma complement-fixing titer was elevated during the recovery.
Case 13, a 17-yr-old female, had a prior mild febrile course for 7 days and then developed a high fever, abdominal pain, and stomatitis. Herpes virus was isolated from the lesion and urine culture grew micrococci. She was exposed to rubella without developing any rash but the antibody titer became elevated. Her absolute lymphocyte count was 230/mm' and returned to 1,560/mm' on the 4th hospital day. Case 14, a 10-yr-old boy, was admitted in a state of shock with a history of minor symptoms for 10 days. Subsequently, he was found to have myocarditis, pericarditis, pleural effusion, hepatic disease, and possible central nervous system lesions. He also developed disseminated intravascular coagulopathy and expired on the 7th day. Postmortem findings revealed that he had disseminated varicella. The virus was isolated from the lung, spleen, and liver. His absolute lymphocyte count was 1,000/mm' on admission and then dropped to 960/mm3. Unfortunately, histological study of the thymus was not done. Although he was previously well and his vaccination history was uneventful, he was known to be exposed to varicella during his early illness and he never developed skin manifestations.
Case 15, a 12-yr-old male, was admitted with a generalized maculopapular rash after a minor illness for 2 wk. Chest X ray showed viral pneumonitis. Profound lymphopenia with a range of 73/mme-336/mme was noted and it was 2 mo before his count was up to normal. His sister had received a rubella vaccine before his illness and had an elevated titer of mycoplasma during the recovery. He did not have any clinical problems while he had prolonged lymphopenia.
These five cases were previously healthy and all had complete immunizations without any problems. Most of the immunological tests done during hospitalizations were normal except for slightly low IgM and complement in Case 14 and a low phytohemagglutinin transformation in Case 7.
